Skip to main content

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Mª Pilar Felipe Fernandez

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Fátima Sol Cabrera

Fátima Sol Cabrera

Research technician
Cardiovascular Diseases
Read more
Samuel Sánchez Pous

Samuel Sánchez Pous

Predoctoral researcher
Clinical Neuroimmunology
Read more
Ferran Ramirez Viaplana

Ferran Ramirez Viaplana

Research technician
Infectious Diseases
Read more
Monica Anglada Baguena

Monica Anglada Baguena

Coordinador/a
Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.